-
Medical journals
- Career
Articles on this topicBiological Treatment
Therapy Change from Adalimumab to Baricitinib in Patients with Rheumatoid Arthritis
The aim of the presented analysis of data from the RA-BEAM study was to evaluate the clinical…30. 3. 2020 Source: Biological Treatment
Persistence of Treatment with Secukinumab and Ixekizumab in Patients with Moderate to Severe Psoriasis
Although IL-17 targeted drugs are increasingly used in the treatment of moderate to severe…21. 2. 2020 Source: Biological Treatment
Pain Relief and Functional Score Improvement in Patients with Low Rheumatoid Arthritis Activity: Baricitinib vs. Adalimumab
In patients with rheumatoid arthritis, pain and functional impairment may persist even with…20. 2. 2020 Source: Biological Treatment
Efficacy and Speed of Pain Relief in Rheumatoid Arthritis When Adding Baricitinib to Methotrexate
The phase III clinical trial RA-BEAM conducted in patients with rheumatoid arthritis (RA)…17. 2. 2020 Source: Biological Treatment
1 2LoginSubscribe
Conferences news
Go to records
Most read on this topic- Alopecia Areata – Autoimmune Inflammatory Disease and a New Targeted Treatment Option
- How do IL-17 and IL-23 inhibitors fare in the treatment of psoriasis in direct comparison?
- Experiences with Long-term Treatment of Psoriasis with Interleukin 17A Inhibitor
- New Therapeutic Options in Light of Current Knowledge on the Pathogenesis of Atopic Dermatitis
- Improvement of Joint and Skin Symptoms and Their Contribution to Improving the Quality of Life in Patients with Psoriatic Arthritis
- Biological treatment of psoriatic arthritis in the 1st line – results of the SPIRIT-H2H study after 1 year of follow-up
Journal on this topic
Related topic
Interesting linksLogin#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career